Study of Adaptive Immunotherapy With VEGFR-TKI in Patients With Advanced RCC
Clinical trial NCT06860386 · SUSPENDED
Trial details
- NCT number
- NCT06860386
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- SUSPENDED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-25
- Primary completion
- 2026-09-01
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.